Esophageal cancer (EC) is one of essentially the most malignant and deadly digestive‑associated tumors worldwide. However, acquired drug resistance is a significant impediment regarding anticancer chemotherapy. An growing quantity of research have reported that microRNAs (miRNAs/miRs) are implicated in regulating the sensitivity of drug resistance in esophageal squamous cell carcinoma (ESCC). The intention of the… Continue reading
